Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deaglio, S.
Right arrow Articles by Malavasi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deaglio, S.
Right arrow Articles by Malavasi, F.
Related Collections
Right arrow Immunobiology
Right arrow Signal Transduction
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 April 2002, Vol. 99, No. 7, pp. 2490-2498

IMMUNOBIOLOGY

Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells

Silvia Deaglio, Mercedes Zubiaur, Armando Gregorini, Flavia Bottarel, Clara M. Ausiello, Umberto Dianzani, Jaime Sancho, and Fabio Malavasi

From the Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry, University of Torino Medical School, Torino, Italy; the Experimental Medicine Research Center, Torino, Italy; the Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine, Consejo Superior de Investigaciones Científicas, Granada, Spain; the Institute of Biology and Genetics, University of Ancona Medical School, Ancona, Italy; the Department of Medical Science, A. Avogadro University of Eastern Piedmont, Novara, Italy; and the Department of Bacteriology and Medical Mycology, Istituto Superiore di Sanità, Rome, Italy.

CD38, a surface glycoprotein of unrestricted lineage, is an ectoenzyme (adenosine diphosphate [ADP] ribosyl cyclase/cyclic ADP-ribose hydrolase) that regulates cytoplasmic calcium. The molecule also performs as a receptor, modulating cell-cell interactions and delivering transmembrane signals, despite showing a structural ineptitude to the scope. CD38 ligation by agonistic monoclonal antibodies induced signals leading to activation of the lytic machinery of natural killer (NK) cells from adults; similar signals could not be reproduced in YT and NKL, 2 CD16- human NK-like lines. It was hypothesized that CD38 establishes a functional cooperation with professional signaling molecules of the NK cell surface. The present work answers the question about the molecule exploited by CD38 for signaling in NK cells, using as a model CD16- NK lines genetically corrected for CD16 expression. Our results indicate that a functional CD16 molecule is a necessary and sufficient requisite for CD38 to control an activation pathway, which includes calcium fluxes, tyrosine phosphorylation of ZAP70 and mitogen-activated protein kinase, secretion of interferon-gamma , and cytotoxic responses. Fluorescence resonance energy transfer and cocapping experiments also showed a surface proximity between CD38 and CD16. These results were confirmed by using the NKL cell line, in which CD16+ and CD16- variants were obtained without genetic manipulation. Together, our findings show CD38 to be a unique receptor molecule that cannot signal by itself but whose receptor function is rescued by functional and physical associations with a professional signaling structure that varies according to lineage and environment. This molecule is CD16 in NK cells.

© 2002 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
F. Malavasi, S. Deaglio, A. Funaro, E. Ferrero, A. L. Horenstein, E. Ortolan, T. Vaisitti, and S. Aydin
Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology
Physiol Rev, July 1, 2008; 88(3): 841 - 886.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad
Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination
J. Leukoc. Biol., July 1, 2008; 84(1): 27 - 49.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Deaglio, T. Vaisitti, S. Aydin, L. Bergui, G. D'Arena, L. Bonello, P. Omede, M. Scatolini, O. Jaksic, G. Chiorino, et al.
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential
Blood, December 1, 2007; 110(12): 4012 - 4021.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Gallay, L. Anani, A. Lopez, P. Colombat, C. Binet, J. Domenech, B. B. Weksler, F. Malavasi, and O. Herault
The Role of Platelet/Endothelial Cell Adhesion Molecule 1 (CD31) and CD38 Antigens in Marrow Microenvironmental Retention of Acute Myelogenous Leukemia Cells
Cancer Res., September 15, 2007; 67(18): 8624 - 8632.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Deaglio, T. Vaisitti, R. Billington, L. Bergui, P. Omede', A. A. Genazzani, and F. Malavasi
CD38/CD19: a lipid raft-dependent signaling complex in human B cells
Blood, June 15, 2007; 109(12): 5390 - 5398.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Deaglio, T. Vaisitti, S. Aydin, E. Ferrero, and F. Malavasi
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia
Blood, August 15, 2006; 108(4): 1135 - 1144.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Frasca, G. Fedele, S. Deaglio, C. Capuano, R. Palazzo, T. Vaisitti, F. Malavasi, and C. M. Ausiello
CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells
Blood, March 15, 2006; 107(6): 2392 - 2399.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.-T. Zilber, N. Setterblad, T. Vasselon, C. Doliger, D. Charron, N. Mooney, and C. Gelin
MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes
Blood, November 1, 2005; 106(9): 3074 - 3081.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Deaglio, T. Vaisitti, L. Bergui, L. Bonello, A. L. Horenstein, L. Tamagnone, L. Boumsell, and F. Malavasi
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival
Blood, April 15, 2005; 105(8): 3042 - 3050.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
S. Deaglio, T. Vaisitti, and F. Malavasi
CD38 Ligation in B-Chronic Lymphocytic Leukemia Cells Induces Sequential Tyrosine Phosphorylation of ZAP70, PLC- {gamma}2 and ERK1/2 Proteins.
Blood (ASH Annual Meeting Abstracts), November 16, 2004; 104(11): 959 - 959.
[Abstract] [Full Text]


Home page
BloodHome page
T. D. Shanafelt, S. M. Geyer, and N. E. Kay
Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL
Blood, February 15, 2004; 103(4): 1202 - 1210.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Deaglio, A. Capobianco, L. Bergui, J. Durig, F. Morabito, U. Duhrsen, and F. Malavasi
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells
Blood, September 15, 2003; 102(6): 2146 - 2155.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. Tenca, A. Merlo, D. Zarcone, D. Saverino, S. Bruno, A. De Santanna, D. Ramarli, M. Fabbi, C. Pesce, S. Deaglio, et al.
Death of T cell precursors in the human thymus: a role for CD38
Int. Immunol., September 1, 2003; 15(9): 1105 - 1116.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Wiestner, A. Rosenwald, T. S. Barry, G. Wright, R. E. Davis, S. E. Henrickson, H. Zhao, R. E. Ibbotson, J. A. Orchard, Z. Davis, et al.
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile
Blood, June 15, 2003; 101(12): 4944 - 4951.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. French, D. K. Walters, and D. F. Jelinek
Transactivation of gp130 in Myeloma Cells
J. Immunol., April 1, 2003; 170(7): 3717 - 3723.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Righi, S. Deaglio, C. Pecchioni, A. Gregorini, A. L. Horenstein, G. Bussolati, A. Sapino, and F. Malavasi
Role of CD31/Platelet Endothelial Cell Adhesion Molecule-1 Expression in in Vitro and in Vivo Growth and Differentiation of Human Breast Cancer Cells
Am. J. Pathol., April 1, 2003; 162(4): 1163 - 1174.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Durig, H. Nuckel, A. Huttmann, E. Kruse, T. Holter, K. Halfmeyer, A. Fuhrer, R. Rudolph, N. Kalhori, A. Nusch, et al.
Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia
Blood, April 1, 2003; 101(7): 2748 - 2755.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Deaglio, A. Capobianco, A. Cali, F. Bellora, F. Alberti, L. Righi, A. Sapino, C. Camaschella, and F. Malavasi
Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum
Blood, November 15, 2002; 100(10): 3782 - 3789.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020